C12N 2730/10163
By chemical treatment
Official title: by chemical treatment
C12N2730/10163 (By chemical treatment) appears on 12 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 16
- Assignees
- 8
- Inventors
- 16
- Latest grant
- 8 Sep 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 2 | 5 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Nucleic acid amplification controls8 Sep 2015US 9,127,048 B2ZeptoMetrix Corporation
- Nucleic acid amplification controls1 Sep 2015US 9,120,849 B2ZeptoMetrix Corporation
- Modified viral particles with immunogenic properties and reduced lipid content5 Aug 2008US 7,407,662 B2Lipid Sciences, Inc.
- Modified immunodeficiency virus particles5 Aug 2008US 7,407,663 B2Lipid Sciences, Inc.
- Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group25 Jun 2002US 6,410,219 B1Cerus Corporation
- Nucleic acid amplification controls20 Apr 2017US 2017/0107585 A1ZeptoMetrix Corporation
- Nucleic acid amplification controls24 Dec 2015US 2015/0368727 A1ZeptoMetrix Corporation
- Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases20 Feb 2014US 2014/0050763 A1Eli Lilly and Company
- Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases29 Jan 2009US 2009/0028902 A1Lipid Sciences, Inc.
- Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases30 Oct 2008US 2008/0267997 A1Lipid Sciences, Inc.
Most cited
By later US patents
- Method for inactivating pathogens in red cell compositions using quinacrine mustard63US 5,691,132 ACerus Corporation · 1997
- Treating red blood cell solutions with anti-viral agents57US 5,559,250 ASteritech, Inc. · 1996
- Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety47US 6,171,777 B2Cerus Corporation · 2001
- Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group36US 6,410,219 B1Cerus Corporation · 2002
- Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety35US 6,143,490 ACerus Corporation · 2000